Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

ARIAD Pharmaceuticals Inc (NASDAQ:ARIA)

9.89
Delayed Data
As of Aug 28
 +2.91 / +41.69%
Today’s Change
4.90
Today|||52-Week Range
10.07
+43.96%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2011

2012

2013

2014
Revenue and IncomeNet Revenues25.3M558.0K45.6M105.4M
 
 
 
 
 
Cost of Goods Sold----5.5M817.0K
 
 
 
Depreciation And Amortization4.6M3.0M4.1M8.8M
 
 
 
 
 
 
Operating ExpensesGross Income----35.9M95.8M
 
 
 
General Expenses97.5M197.8M304.7M256.0M
 
 
 
 
 
Research And Development77.7M139.9M160.7M120.6M
 
 
 
 
 
Total Operating Expenses102.1M200.8M314.3M265.6M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-76.8M-200.3M-268.8M-160.2M
 
 
 
 
 
Extraordinary Credit0.00--0.004.8M
 
 
Extraordinary Charge-46.7M-20.7M-4.8M0.00
 
 
 
 
Interest Expense On Debt232.0K199.0K153.0K8.1M
 
 
 
 
 
Other Expenses0.0071.0K-130.0K1.4M
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-123.6M-220.9M-273.7M-162.0M
 
 
 
 
 
Income Taxes0.000.00-439.0K-630.0K
 
 
 
Net Income-123.6M-220.9M-274.2M-162.6M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS132.4M165.0M183.6M186.8M
 
 
 
 
 
Shares To Calculate EPS Diluted132.4M165.0M183.6M186.8M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.93-$1.34-$1.49-$0.87
 
 
 
 
 
EPS Diluted-$0.93-$1.34-$1.49-$0.87